Please enter both email and password to log in
You need to upgrade your Flash Player
|
You need to upgrade your Flash Player to view this content.
What's New?
New CME-certified case study!
The Role of Nonpharmacologic and Lipid-Lowering Therapies in a Patient With Low Framingham-Assessed Cardiovascular Risk. M. Dominique Ashen, PhD, CRNP, and CCMD Faculty Member Roger S. Blumenthal, MD, explore nonpharmacologic and lipid-lowering treatments for a patient with evidence of increased cardiovascular risk beyond that suggested by Framingham Risk Scoring. Earn 0.75 AMA PRA Category 1 Credit™ and access to an anthology of CCMD slides instantly!
|
CMDManagement™ Fall 2008 issue now available for CME credit!
This issue of our award-winning newsletter explores the assessment of CVD risk using nontraditional risk factors. Also featured: a case study by Erin Michos, MD, MHS, exploring cardiovascular risk stratification in women and younger adults, and a patient handout focusing on managing risk factors for stroke.
|
FDA Alert: Simvastatin With Amiodarone Increases Risk of Rhabdomyolysis
On August 8 ,2008, the FDA released a warning regarding reports of increased rhabdomyolysis risk from concomitant use of simvastatin greater than 20 mg qd and amiodarone, an arrhythmia treatment for controlling life-threatening recurrent ventricular arrhythmias. In its alert, the FDA noted that all statins have a potential risk of rhabdomyolysis, whether or not they are administered with amiodarone, but the risk is more prominent when used with the arrhythmia agent.
|
OnsiteInsight® from AHA Scientific Sessions 2008!
This issue of OnsiteInsight® highlights clinical-trial results and scientific sessions focusing on issues in the management of atherosclerosis from the American Heart Association Scientific Sessions 2008 in New Orleans! Also featured: expert commentary from CCMD Education Council Member JoAnne M. Foody, MD.
|
NDEI.org Interactive Case Study
NDEI Faculty Member Mark W. Stolar, MD, discusses management of a 47-year-old Hispanic man with type 2 diabetes who presents with sleep apnea and occult depression
|
In the News
Could Curvy Hips And Bum Protect Women From Diabetes? UK
Jan 14, 2009 -- New research claims that fat around the hips and bottom can help protect women from developing diabetes. The study was carried out on mice at Harvard Medical School. Researchers found that fat that collects around the stomach can raise the risk of Type 2 diabetes and heart disease. However, they claim that those with pear-shaped bodies, with fat deposits in the buttocks and hips, are less prone to these conditions.
|
Cell 'Anchors' Required To Prevent Muscular Dystrophy
Jan 14, 2009 -- A protein that was first identified for playing a key role in regulating normal heart rhythms also appears to be significant in helping muscle cells survive the forces of muscle contraction. The clue was a laboratory mouse that seemed to have a form of muscular dystrophy. A group of proteins called ankyrins, or anchor proteins, were first discovered in human red blood cells by Vann Bennett, M.D. a Howard Hughes Medical Institute investigator and James B.
|
|
|
|
|
CCMD Co-Chairmen
|
Education Council
George L. Bakris, MD
|
Elizabeth Barrett-Connor, MD
|
Keith C. Ferdinand, MD
|
JoAnne M. Foody, MD
|
Peter Ganz, MD
|
Philip B. Gorelick, MD, MPH
|
Scott M. Grundy, MD, PhD
|
Steven M. Haffner, MD
|
Ronald M. Krauss, MD
|
John C. LaRosa, MD
|
Peter Libby, MD
|
Thomas A. Pearson, MD, MPH, PhD
|
|
|